Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 3
2013 1
2015 1
2016 1
2017 1
2018 1
2019 3
2020 8
2021 13
2022 8
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review.
Oliva Ramirez A, Keenan A, Kalau O, Worthington E, Cohen L, Singh S. Oliva Ramirez A, et al. BMC Neurol. 2021 Dec 2;21(1):468. doi: 10.1186/s12883-021-02396-1. BMC Neurol. 2021. PMID: 34856949 Free PMC article.
BACKGROUND: Multiple sclerosis (MS) is a chronic, demyelinating disease of the central nervous system that results in progressive and irreversible disability. ...
BACKGROUND: Multiple sclerosis (MS) is a chronic, demyelinating disease of the central nervous system that results in progress …
Sexual dysfunction therapeutic approaches in patients with multiple sclerosis: a systematic review.
Giannopapas V, Kitsos D, Tsogka A, Tzartos JS, Paraskevas G, Tsivgoulis G, Voumvourakis K, Giannopoulos S, Bakalidou D. Giannopapas V, et al. Neurol Sci. 2023 Mar;44(3):873-880. doi: 10.1007/s10072-022-06572-0. Epub 2022 Dec 31. Neurol Sci. 2023. PMID: 36585597 Free PMC article. Review.
OBJECTIVE: Multiple sclerosis (MS) is the most common chronic inflammatory demyelinating disease of the central nervous system (CNS). The most common clinical manifestations of MS are spasticity, pain, vesico-urethral disorders, cognitive impairments, chronic fatigu …
OBJECTIVE: Multiple sclerosis (MS) is the most common chronic inflammatory demyelinating disease of the central nervous system …
Dietary interventions for multiple sclerosis-related outcomes.
Parks NE, Jackson-Tarlton CS, Vacchi L, Merdad R, Johnston BC. Parks NE, et al. Cochrane Database Syst Rev. 2020 May 19;5(5):CD004192. doi: 10.1002/14651858.CD004192.pub4. Cochrane Database Syst Rev. 2020. PMID: 32428983 Free PMC article.
BACKGROUND: Multiple sclerosis (MS) is a common demyelinating disease of the central nervous system. Although the exact pathogenesis remains unknown, the leading theory is that it results from immune system dysregulation. ...
BACKGROUND: Multiple sclerosis (MS) is a common demyelinating disease of the central nervous system. Although the exact pathog …
Alemtuzumab for multiple sclerosis.
Riera R, Torloni MR, Martimbianco ALC, Pacheco RL. Riera R, et al. Cochrane Database Syst Rev. 2023 Jun 5;6(6):CD011203. doi: 10.1002/14651858.CD011203.pub3. Cochrane Database Syst Rev. 2023. PMID: 37272540 Free PMC article. Review.
BACKGROUND: Multiple sclerosis (MS) is an autoimmune, T-cell-dependent, inflammatory, demyelinating disease of the central nervous system, with an unpredictable course. ...
BACKGROUND: Multiple sclerosis (MS) is an autoimmune, T-cell-dependent, inflammatory, demyelinating disease of the central ner …
Association of CNS demyelination and COVID-19 infection: an updated systematic review.
Ismail II, Salama S. Ismail II, et al. J Neurol. 2022 Feb;269(2):541-576. doi: 10.1007/s00415-021-10752-x. Epub 2021 Aug 12. J Neurol. 2022. PMID: 34386902 Free PMC article. Review.
The following keywords were used: "COVID-19", "SARS-CoV-2", "demyelination", "demyelinating disease", "multiple sclerosis", "neuromyelitis optica", and "transverse myelitis". ...
The following keywords were used: "COVID-19", "SARS-CoV-2", "demyelination", "demyelinating disease", "multiple sclerosis", "n …
Statins for multiple sclerosis.
Wang J, Xiao Y, Luo M, Luo H. Wang J, et al. Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD008386. doi: 10.1002/14651858.CD008386.pub3. Cochrane Database Syst Rev. 2011. PMID: 22161428 Free PMC article. Review.
BACKGROUND: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the human central nervous system. Statins, prescribed as cholesterol lowering agents, have shown possible effects for treating MS in experimental and preliminary clinical studies. ...
BACKGROUND: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the human central nervous system. Statins, pre …
Alemtuzumab for multiple sclerosis.
Riera R, Porfírio GJ, Torloni MR. Riera R, et al. Cochrane Database Syst Rev. 2016 Apr 15;4(4):CD011203. doi: 10.1002/14651858.CD011203.pub2. Cochrane Database Syst Rev. 2016. PMID: 27082500 Free PMC article. Updated. Review.
BACKGROUND: Multiple sclerosis (MS) is an autoimmune, T-cell-dependent, inflammatory, demyelinating disease of the central nervous system, with an unpredictable course. ...
BACKGROUND: Multiple sclerosis (MS) is an autoimmune, T-cell-dependent, inflammatory, demyelinating disease of the central ner …
Statins for multiple sclerosis.
Wang J, Xiao Y, Luo M, Zhang X, Luo H. Wang J, et al. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008386. doi: 10.1002/14651858.CD008386.pub2. Cochrane Database Syst Rev. 2010. PMID: 21154395 Updated. Review.
BACKGROUND: Multiple sclerosis is an inflammatory demyelinating disease of the human central nervous system. Statins, prescribed as cholesterol lowering agents, have shown beneficial effects for treating MS in experimental and preliminary clinical studies. ...
BACKGROUND: Multiple sclerosis is an inflammatory demyelinating disease of the human central nervous system. Statins, prescrib …
Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review.
Cruz Fernández-Espartero M, Pérez-Zafrilla B, Naranjo A, Esteban C, Ortiz AM, Gómez-Reino JJ, Carmona L; BIOBADASER Study Group. Cruz Fernández-Espartero M, et al. Semin Arthritis Rheum. 2011 Dec;41(3):524-33. doi: 10.1016/j.semarthrit.2011.05.003. Semin Arthritis Rheum. 2011. PMID: 22152489 Review.
RESULTS: In 21,425 patient-years in BIOBADASER, there were 9 patients with confirmed demyelinating disease, 4 with optic neuritis, and 1 with MS. In addition, 22 patients presented polyneuropathies, paresthesias, dysesthesias, facial palsy, or vocal cord paralysis w …
RESULTS: In 21,425 patient-years in BIOBADASER, there were 9 patients with confirmed demyelinating disease, 4 with optic neuri …
44 results